Stock Scorecard



Stock Summary for Axogen Inc (AXGN) - $13.30 as of 11/20/2024 7:47:40 PM EST

Total Score

7 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AXGN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AXGN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AXGN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for AXGN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for AXGN (29 out of 90)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0

Latest News for for AXGN

Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist 11/7/2024 1:00:00 PM
TransMedics ( TMDX ) Q3 Earnings and Revenues Miss Estimates 10/28/2024 9:30:00 PM
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 - Axogen ( NASDAQ:AXGN ) 10/24/2024 11:00:00 AM
AxoGen ( AXGN ) Surges 8.2%: Is This an Indication of Further Gains? 10/14/2024 11:21:00 AM
BRKR Stock Might Gain From the Newly Launched OptoVolt Module 10/9/2024 12:44:00 PM
Here's Why You Should Retain Penumbra Stock in Your Portfolio Now 10/9/2024 12:43:00 PM
Reasons to Retain Chemed Stock in Your Portfolio Now 10/8/2024 2:22:00 PM
TMO's New ICP-MS Systems Boost Trace Element Analysis: Stock to Gain? 10/8/2024 1:51:00 PM
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors - Axogen ( NASDAQ:AXGN ) , Bruker ( NASDAQ:BRKR ) 10/7/2024 7:45:00 PM
Reasons to Retain QIAGEN Stock in Your Portfolio for Now 10/7/2024 6:15:00 PM

Financial Details for AXGN

Company Overview

Ticker AXGN
Company Name Axogen Inc
Country USA
Description AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.
Sector Name LIFE SCIENCES
Industry Name ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 13.30
Price 4 Years Ago 17.90
Last Day Price Updated 11/20/2024 7:47:40 PM EST
Last Day Volume 333,192
Average Daily Volume 426,459
52-Week High 15.90
52-Week Low 5.55
Last Price to 52 Week Low 139.64%

Valuation Measures

Trailing PE N/A
Industry PE 46.45
Sector PE 40.32
5-Year Average PE 0.82
Free Cash Flow Ratio 23.75
Industry Free Cash Flow Ratio 20.82
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 3.74
Total Cash Per Share 0.56
Book Value Per Share Most Recent Quarter 2.26
Price to Book Ratio 5.64
Industry Price to Book Ratio 4.06
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 3.10
Industry Price to Sales Ratio Twelve Trailing Months 3.24
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 44,008,300
Market Capitalization 585,310,390
Institutional Ownership N/A

Dividends

Ex-Dividend Date 1/27/2010
Last Dividend Amount 0.06
Current Dividend Amount 1.00
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 1,566.67%
3-Year Dividend Growth Rate Percentage 1,566.67%
5-Year Dividend Growth Rate Percentage 1,566.67%
All-Time Dividend Growth Rate Percentage 1,566.67%
Dividend Payout Ratio 0.00%

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 24.98%
Reported EPS 12 Trailing Months -0.33
Reported EPS Past Year 0.06
Reported EPS Prior Year -0.18
Net Income Twelve Trailing Months -14,307,000
Net Income Past Year -21,716,000
Net Income Prior Year -28,948,000
Quarterly Revenue Growth YOY 17.90%
5-Year Revenue Growth 13.63%
Operating Margin Twelve Trailing Months -0.01

Balance Sheet

Total Cash Most Recent Quarter 24,530,000
Total Cash Past Year 31,024,000
Total Cash Prior Year 48,789,000
Net Cash Position Most Recent Quarter -22,742,000
Net Cash Position Past Year -15,579,000
Long Term Debt Past Year 46,603,000
Long Term Debt Prior Year 45,712,000
Total Debt Most Recent Quarter 47,272,000
Equity to Debt Ratio Past Year 0.67
Equity to Debt Ratio Most Recent Quarter 0.68
Total Stockholder Equity Past Year 95,665,000
Total Stockholder Equity Prior Year 100,999,000
Total Stockholder Equity Most Recent Quarter 99,407,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -9,899,000
Free Cash Flow Per Share Twelve Trailing Months -0.22
Free Cash Flow Past Year -20,634,000
Free Cash Flow Prior Year -37,319,000

Options

Put/Call Ratio 0.43
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.23
MACD Signal -0.04
20-Day Bollinger Lower Band 8.32
20-Day Bollinger Middle Band 12.24
20-Day Bollinger Upper Band 16.16
Beta 1.13
RSI 43.53
50-Day SMA 9.47
150-Day SMA 8.95
200-Day SMA 11.06

System

Modified 11/20/2024 6:40:19 PM EST